We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
HSBC
HSBC
$354B
| $262K | ﹤0.01% |
7,747
-3,900
| -33% | -$122K |
|
|
PUB
1002
DELISTED
PUBLICIS SA ADS (1 ADS = 1C0M)
PUB
| $262K | ﹤0.01% |
13,961
+13,833
| +10,807% | +$260K |
|
1003
Texas Roadhouse
TXRH
$13.2B
| $261K | ﹤0.01% |
6,701
-557,463
| -99% | -$24.9M |
|
|
GS.PRB.CL
1004
DELISTED
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
| $261K | ﹤0.01% |
10,000
| – | – |
|
|
OMED
1005
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $261K | ﹤0.01% |
22,900
-5,800
| -20% | -$67.5K |
|
1006
CONMED
CNMD
$1.3B
| $260K | ﹤0.01% |
6,511
| – | – |
|
1007
Bankunited
BKU
$3.38B
| $259K | ﹤0.01% |
8,594
-191
| -2% | -$5.86K |
|
1008
Freeport-McMoran
FCX
$88.8B
| $258K | ﹤0.01% |
23,886
-1,053
| -4% | -$12.1K |
|
1009
Sally Beauty Holdings
SBH
$1.43B
| $258K | ﹤0.01% |
10,116
| – | – |
|
1010
Broadridge
BR
$17.8B
| $255K | ﹤0.01% |
3,769
-60
| -2% | -$4.09K |
|
1011
Columbia Sportswear
COLM
$3.23B
| $255K | ﹤0.01% |
4,523
+472
| +12% | +$26.9K |
|
1012
Westamerica Bancorp
WABC
$1.38B
| $255K | ﹤0.01% |
5,030
| – | – |
|
1013
Autodesk
ADSK
$47.8B
| $254K | ﹤0.01% |
3,524
-750
| -18% | -$47.3K |
|
1014
American International
AIG
$42.1B
| $254K | ﹤0.01% |
4,294
+212
| +5% | +$12.1K |
|
1015
Salesforce
CRM
$144B
| $252K | ﹤0.01% |
3,545
+762
| +27% | +$59.4K |
|
|
SKX
1016
DELISTED
Skechers
SKX
| $250K | ﹤0.01% |
10,986
+7,020
| +177% | +$179K |
|
1017
MGE Energy Inc
MGEE
$3.07B
| $249K | ﹤0.01% |
4,435
+662
| +18% | +$37.3K |
|
1018
S&T Bancorp
STBA
$1.88B
| $248K | ﹤0.01% |
8,580
| – | – |
|
1019
iShares Silver Trust
SLV
$28.2B
| $247K | ﹤0.01% |
13,625
+4,500
| +49% | +$83.8K |
|
|
SLCA
1020
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $246K | ﹤0.01% |
5,309
+24
| +0.5% | +$935 |
|
|
TEF
1021
DELISTED
Telefonica
TEF
| $245K | ﹤0.01% |
31,473
+19,301
| +159% | +$149K |
|
1022
Westlake Chemical Partners
WLKP
$773M
| $245K | ﹤0.01% |
10,770
+3,710
| +53% | +$84.2K |
|
1023
HubSpot
HUBS
$11.7B
| $243K | ﹤0.01% |
4,222
-123
| -3% | -$6.67K |
|
1024
NBT Bancorp
NBTB
$2.73B
| $243K | ﹤0.01% |
7,396
| – | – |
|
|
ISEE
1025
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $238K | ﹤0.01% |
+5,172
| New | +$292K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.